Anne B. Vogt
Boehringer Ingelheim RCV GmBH & Co KG, Dr. Boehringer Gasse 5-11
Vienna, 1120, Austria
Vienna, 1120, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Single-cell transcriptomic analysis identifies tissue-specific fibroblasts as the main modulators of myeloid cells in peritoneal metastasis of different origin.
Journal: Cancer letters
Published: December 20, 2024
Dysfunctional tumor-infiltrating Vδ1 + T lymphocytes in microsatellite-stable colorectal cancer.
Journal: Nature communications
Published: June 23, 2023
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.
Journal: Frontiers in immunology
Published: August 01, 2022
A Novel B7-H6-Targeted IgG-Like T Cell-Engaging Antibody for the Treatment of Gastrointestinal Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 06, 2022
Combination of two novel blocking antibodies, anti-PD-1 antibody ezabenlimab (BI 754091) and anti-LAG-3 antibody BI 754111, leads to increased immune cell responses.
Journal: Oncoimmunology
Published: June 27, 2022
Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction.
Journal: Frontiers in immunology
Published: January 26, 2022
A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway.
Journal: Molecular cancer therapeutics
Published: February 03, 2021
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.
Journal: Cell
Published: January 28, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026